embryonic stem cell-derived cd15+ isl-1+ progenitors
Cell therapyexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2013 (NCT02057900)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Cardiac muscle cellTissue restoration
Cardiac muscle cell tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- embryonic stem cell-derived cd15+ isl-1+ progenitors
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02057900 | Phase 1 | Jun 1, 2013 | University of Paris |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Paris | Academic/Hospital | 1 | 1 | 1 | 2013 |
1 organizations
Page 1 / 1